Exposed | Unexposed | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Staff | Patients | Staff | Patients | |||||||||
n=142 | n=134 | n=22 | n=156 | |||||||||
n | % | (95% CI) | n | % | (95% CI) | n | % | (95% CI) | n | % | (95% CI) | |
Age (years), median (range) | 34 | (18 to 69) | 73 | (27 to 95) | 44 | (23 to 60) | 71 | (25 to 93) | ||||
Male, n (%)† | 25 | (17) | 60 | (45) | 7 | (32) | 77 | (49) | ||||
Ethnicity, n (%) | ||||||||||||
White Caucasian | - | - | 133 | (99) | 20 | (91) | 156 | (100) | ||||
Hispanic | - | - | 1 | (0.7) | 0 | (0) | 0 | (0) | ||||
Asian‡ | - | - | 0 | (0) | 2 | (9) | 0 | (0) | ||||
BCG (history or scar), n (%) | ||||||||||||
Yes | 119 | (84) | 55 | (41) | 18 | (82) | 75 | (48) | ||||
No | 8 | (5.6) | 57 | (43) | 3 | (14) | 50 | (32) | ||||
Unknown | 1 | (0.7) | 22 | (16) | 1 | (5) | 30 | (19) | ||||
TSpot result including initial borderline results, n, (%) (95%CI) | ||||||||||||
Positive | 14 | (9.9) | (5.0 to 15) | 28 | (21) | (14 to 27) | 2 | (9.1) | (0 to 21) | 13 | (8.3) | (4.0 to 13) |
Borderline positive | 2§ | (1.4) | (0 to 3.3) | 3 | (2.2) | (0 to 4.7) | 0 | (0) | (N/A) | 5 | (3.2) | (0.44 to 6.0) |
Borderline negative | 6§ | (4.2) | (0.92 to 7.5) | 1 | (0.7) | (0 to 2.2) | 1 | (4.5) | (0 to 13) | 2 | (1.3) | (0 to 3.0) |
Negative | 120 | (85) | (79 to 90) | 102 | (76) | (68 to 82) | 19 | (86) | (72 to 100) | 136 | (87) | (82 to 92) |
TSpot result excluding those borderline results which were not retested, n, (%) (95%CI) | ||||||||||||
Positive | 16 | (11) | (6.1 to 16) | 28 | (22) | (14 to 29) | 2 | (9.5) | (0 to 22) | 13 | (8.7) | (4.2 to 13) |
Negative | 126 | (89) | (84 to 94) | 102 | (78) | (71 to 85) | 19 | (90) | (78 to 100) | 136 | (91) | (87 to 96) |